Regulation of Artificial Intelligence in Veterinary Medicine

Artificial intelligence (AI) tools are rapidly being adopted in veterinary medicine. Unlike human medicine, where the Food and Drug Administration has established comprehensive pre-market approval pathways for AI-enabled medical devices, veterinary AI tools are marketed and deployed without regulatory oversight, independent validation, or post-market surveillance. This article examines the current regulatory landscape for veterinary AI across the United States, European Union, and United Kingdom, and explores the roles of professional organizations in establishing standards through position statements and task forces. Liability and data privacy considerations are discussed, along with practical guidance for practitioners evaluating and adopting AI tools.